Why the Adderall Shortage Has Lasted So Long |Pacific Updates

[ad_1] In October 2022, the U.S. Food and Drug Administration (FDA) announced a shortage of amphetamine mixed salts—a drug category that includes Adderall, the stimulant medication often used to treat attention-deficit/hyperactivity disorder (ADHD). In the six months since, little has changed. Numerous amphetamine mixed salts products are still in short supply, although certain manufacturers expect…

Read More